Pharmacokinetic interaction involving fenofibrate and everolimus
Ann Oncol
.
2015 Jan;26(1):248-249.
doi: 10.1093/annonc/mdu492.
Epub 2014 Oct 30.
Authors
O Mir
1
,
V Poinsignon
2
,
M Arnedos
3
,
S Delaloge
3
,
A Paci
2
Affiliations
1
Department of Cancer Medicine, Breast Group. Electronic address: olivier.mir@gustaveroussy.fr.
2
Department of Pharmacology, Gustave Roussy Cancer Institute, Villejuif, France.
3
Department of Cancer Medicine, Breast Group.
PMID:
25361989
DOI:
10.1093/annonc/mdu492
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms / drug therapy*
Drug-Related Side Effects and Adverse Reactions / drug therapy*
Female
Humans
Sirolimus / analogs & derivatives*
Substances
Sirolimus